CADENCE PHARMACEUTICALS INC·4

Dec 18, 5:58 PM ET

CRAIG WILLIAM S 4

4 · CADENCE PHARMACEUTICALS INC · Filed Dec 18, 2009

Insider Transaction Report

Form 4
Period: 2009-12-17
Transactions
  • Sale

    Common stock

    2009-12-17$10.00/sh10,000$100,0002,000 total
  • Exercise/Conversion

    Common stock

    2009-12-17$0.40/sh+5,000$2,0007,000 total
  • Exercise/Conversion

    Stock option (right to buy)

    2009-12-175,00055,000 total
    Exercise: $0.40From: 2005-02-16Exp: 2015-02-15common stock (5,000 underlying)
  • Exercise/Conversion

    Common stock

    2009-12-17$1.36/sh+5,000$6,80012,000 total
  • Exercise/Conversion

    Stock option (right to buy)

    2009-12-175,00083,825 total
    Exercise: $1.36From: 2006-05-09Exp: 2016-05-08common stock (5,000 underlying)
Footnotes (2)
  • [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2009.
  • [F2]Not applicable to this transaction.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION